Authors: Carlini, P Frassoldati, A De Marco, S Casali, A Ruggeri, EM Nardi, M Papaldo, P Fabi, A Paoloni, F Cognetti, F

Citation: P. Carlini et al., Formestane, a steroidal aromatase inhibitor after failure of non-steroidalaromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?, ANN ONCOL, 12(11), 2001, pp. 1539-1543

Authors: Faravelli, T Bua, L Frassoldati, A Antifora, A Tognotti, L Ranzi, E

Citation: T. Faravelli et al., A new procedure for predicting NOx emissions from furnaces, COMPUT CH E, 25(4-6), 2001, pp. 613-618

Authors: Cantore, M Pederzoli, P Cornalba, G Fiorentini, G Guadagni, S Miserocchi, L Frassoldati, A Ceravolo, C Smerieri, F Muchmore, JH

Citation: M. Cantore et al., Intra-arterial chemotherapy for unresectable pancreatic cancer, ANN ONCOL, 11(5), 2000, pp. 569-573

Authors: Cocconi, G Bisagni, G Bella, M Aato, L Anastasi, P Carpi, A Di Costanzo, F Frassoldati, A Mosconi, A Borrini, A Buzzi, P

Citation: G. Cocconi et al., Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluourouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer - A prospective randomized study (vol 22, pg 593, 1999), AM J CL ONC, 23(2), 2000, pp. CP3-CP3

Authors: Longo, G Fiorani, C Sacchi, S Callea, V Lombardo, M Federico, M Stelitano, C Angrilli, F Vallisa, D Gobbi, PG Ilariucci, F Frassoldati, A Petrini, M Silingardi, V

Citation: G. Longo et al., Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma, HAEMATOLOG, 84(5), 1999, pp. 425-430

Authors: Cocconi, G Bisagni, G Bella, M Acito, L Anastasi, P Carpi, A Di Costanzo, F Frassoldati, A Mosconi, A Borrini, A Buzzi, P

Citation: G. Cocconi et al., Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer - A prospective randomized study, AM J CL ONC, 22(6), 1999, pp. 593-600